{"university":{"openalex_id":"I155125353","name":"Università Campus Bio-Medico"},"topic":"age-crosslink-breakers","total_matching":3,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.5812/cardiovascmed.31707","title":"Targeting advanced glycation end products in cardiac surgery: The unexplored alternative","source_url":"https://doi.org/10.5812/cardiovascmed.31707","source_name":"Research in Cardiovascular Medicine","cited_by_count":2,"is_open_access":true,"openalex_work_id":"W2209981363","publication_date":"2015-12-26","publication_year":2015,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.4103/2251-9572.218778","title":"Pharmacologic approaches against Advanced Glycation End Products (AGEs) in diabetic cardiovascular disease","source_url":"https://doi.org/10.4103/2251-9572.218778","source_name":"Research in Cardiovascular Medicine","cited_by_count":33,"is_open_access":true,"openalex_work_id":"W4232372023","publication_date":"2015-01-01","publication_year":2015,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.5812/cardiovascmed.4(2)2015.26949","title":"Pharmacologic approaches against Advanced Glycation End Products (AGEs) in diabetic cardiovascular disease","source_url":"https://doi.org/10.5812/cardiovascmed.4(2)2015.26949","source_name":"Research in Cardiovascular Medicine","cited_by_count":84,"is_open_access":true,"openalex_work_id":"W598275130","publication_date":"2015-01-01","publication_year":2015,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}